Mack Gill

Mack Gill

Director/Board Member bei ALTIMMUNE, INC.

Vermögen: 28 209 $ am 31.03.2024

72 Jahre
Health Technology
Technology Services
Finance

Profil

John M.
Gill
founded TetraLogic Pharmaceuticals Corp.
in 2001, where he worked as Director from 2013 to 2014.
Dr. Gill also currently works at Millennium Information Technologies Ltd., as Chief Executive Officer from 2013, Altimmune, Inc., as Independent Director from 2004, and Torstone Technology Ltd., as Chief Operating Officer.
Dr. Gill also formerly worked at PharmAthene, Inc., as President, Chief Executive Officer & Director from 2015 to 2017, 3-Dimensional Pharmaceuticals, Inc., as Chief Financial Officer, Director & Executive VP, PharmAthene, Inc., as Director in 2007, Theraclone Sciences, Inc., as Director, The Biotechnology Greenhouse Corp.
of Southeastern PA, as Director, Ben Franklin Technology Partners, as Director, FIS Capital Markets US LLC (Pennsylvania), as SVP-Corporate Development & Strategy, GSK Equity Investments Ltd., as President, US Department of Defense (District of Columbia), as Principal from 1971 to 1973, Smithkline & French Laboratories US, Inc., as Chief Operating Officer, SunGard Financial Systems, as President-Global Technology, Nova Pharmaceutical Corp., as Chief Operating Officer, GlaxoSmithKline LLC, as VP-Research & Development Operations, and Sungard Global Services France SA, as President in 2011.
Dr. Gill received his undergraduate degree in 1975 from Rutgers State University of New Jersey, graduate degree from Yale University, and undergraduate degree from the University of British Columbia.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
28.09.2023 2 771 ( 0,01% ) 28 209 $ 31.03.2024

Aktive Positionen von Mack Gill

UnternehmenPositionBeginn
ALTIMMUNE, INC. Director/Board Member 01.08.2004
Chief Executive Officer 23.05.2013
Chief Operating Officer -
Alle aktiven Positionen von Mack Gill

Ehemalige bekannte Positionen von Mack Gill

UnternehmenPositionEnde
Chief Executive Officer 01.05.2017
TETRALOGIC PHARMACEUTICALS CORPORATION Founder 29.01.2014
President 01.03.2011
Director/Board Member 30.04.2008
Director/Board Member 03.08.2007
Sehen Sie sich die Erfahrung von Mack Gill im Detail an

Ausbildung von Mack Gill

Rutgers State University of New Jersey Undergraduate Degree
Yale University Graduate Degree
University of British Columbia Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Mack Gill im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
TETRALOGIC PHARMACEUTICALS CORPORATION

Health Technology

ALTIMMUNE, INC.

Health Technology

Private Unternehmen16

Technology Services

Health Technology

Health Technology

Commercial Services

Technology Services

Finance

Finance

US Department of Defense (District of Columbia)

Government

Finance

Health Technology

Smithkline & French Laboratories US, Inc.

Technology Services

Nova Pharmaceutical Corp.

Health Technology

Technology Services

Technology Services

Sehen Sie sich die Unternehmensverbindungen an